Effect of PPIs on Stool DNA Test for H. Pylori
Key facts
- Who runs it
- Shanghai Jiao Tong University School of Medicine
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 49 people enrolled
- Started
- 1 Jun 2025
- Ended
- 30 May 2026
- Type of study
- Observational
- Treatments tested
- Proton Pump Inhibitor Discontinuation
- Record updated
- 1 September 2026
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Male or female patients aged 18-80 years
- No prior H. pylori eradication therapy
- Patients requiring proton pump inhibitor (PPI) therapy in the near future due to gastritis, peptic ulcer disease, or other indicated conditions
- Patients with at least two positive results among H. pylori antibody test, histology, and rapid urease test (RUT)
- Provision of signed informed consent and being informed of the specific study protocol
Who cannot take part
- Prior H. pylori eradication therapy
- Alcohol and/or drug abuse (addiction or dependence), or poor compliance as judged by the investigator
- Acute gastrointestinal bleeding
- History of subtotal gastrectomy
- Severe dysfunction of vital organs (heart, liver, kidney, lungs, etc.) or congenital diseases, such as class IV cardiac insufficiency, liver failure, uremia, respiratory failure, hemophilia, Wilson's disease, etc
- Pregnant or lactating women
- Refusal of enrollment by the guardian or the patient
- Individuals without legal capacity or with impaired insight
- Abnormal neurological signs on physical examination
- Use of oral antibiotics with bactericidal activity against H. pylori within 4 weeks
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective, self-controlled clinical study aims to evaluate the impact of proton pump inhibitor (PPI) use on the accuracy of stool DNA testing for Helicobacter pylori (H. pylori) and to assess the applicability of this test in patients receiving PPI therapy. Patients requiring long-term PPI treatment and meeting the inclusion criteria were enrolled. After at least four weeks of PPI therapy, a stool DNA test was performed, along with collection of gastric mucosal samples via gastroscopy for tissue PCR, histology, and rapid urease testing, as well as H. pylori antibody detection. Subsequently, PPI treatment was discontinued for four weeks, after which a 13C-urea breath test and a repeat stool DNA test were conducted. By comparing the sensitivity, specificity, and consistency of stool DNA testing before and after PPI discontinuation, this study aims to characterize the interference of PPIs with the test results, thereby providing evidence to support improvements in H. pylori diagnostic methods.
Treatments tested
- Proton Pump Inhibitor Discontinuation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Proton Pump Inhibitors on Stool DNA Detection of Helicobacter Pylori: A Prospective Clinical Study
- Record updated
- 1 September 2026